Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced...
Clairvoyant Therapeutics, a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased...
Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety,...
A new generation of patients can be powerful motivators for a pharmaceutical industry historically resistant to change. And if they don’t respect or...
There’s been a steady surge of interest in how and why psychedelics work to potentially cure addiction, especially alcohol addiction, also called alcohol...
Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN)), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to provide...
Wellbeing Digital Sciences Inc. (NEO: MEDI | OTC: KONEF | FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation...
The acquisition is the latest sign of stress among startups in the sector, which has seen valuations plummet. The post Eleusis Holdings Plans To Be Acquired...
The acquisition is the latest sign of stress among startups in the sector, which has seen valuations plummet. The post Eleusis Holdings May Be Acquired...
Wellbeing Digital Sciences Inc. (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation...